IONS — Ionis Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $4.72bn
- $3.67bn
- $705.14m
- 51
- 10
- 61
- 36
Annual cashflow statement for Ionis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -480 | -28.6 | -270 | -366 | -454 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 230 | 154 | -34.3 | 114 | 140 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -73.6 | -114 | 7.57 | -77.3 | -209 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 35.9 | 30.8 | -274 | -308 | -501 |
| Capital Expenditures | -35.1 | -12 | -15.7 | -23.8 | -45.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 310 | 207 | -247 | -190 | -88.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | 274 | 195 | -263 | -214 | -134 |
| Financing Cash Flow Items | -558 | -169 | -11 | 508 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -597 | 246 | -55.3 | 644 | 478 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -286 | 472 | -593 | 123 | -157 |